Correlation Between Genelux Common and Enliven Therapeutics

Can any of the company-specific risk be diversified away by investing in both Genelux Common and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genelux Common and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genelux Common and Enliven Therapeutics, you can compare the effects of market volatilities on Genelux Common and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genelux Common with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genelux Common and Enliven Therapeutics.

Diversification Opportunities for Genelux Common and Enliven Therapeutics

0.51

Correlation Coefficient

Genelux Common  Enliven Therapeutics

Very weak diversification

The 3 months correlation between Genelux and Enliven is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Genelux Common and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Genelux Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genelux Common are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Genelux Common i.e., Genelux Common and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between Genelux Common and Enliven Therapeutics

Given the investment horizon of 90 days Genelux Common is expected to generate 1.83 times more return on investment than Enliven Therapeutics. However, Genelux Common is 1.83 times more volatile than Enliven Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  220.00  in Genelux Common on October 26, 2024 and sell it today you would earn a total of  116.00  from holding Genelux Common or generate 52.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.19%
Values	Daily Returns

Genelux Common  vs.  Enliven Therapeutics

Genelux Common

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Genelux Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Genelux Common showed solid returns over the last few months and may actually be approaching a breakup point.

Enliven Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enliven Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Genelux Common and Enliven Therapeutics

The main advantage of trading using opposite Genelux Common and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genelux Common position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.

The idea behind Genelux Common and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..